Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$38.0K
5.16K shares
What this filing means
SCHOENBERG MARK plans to sell 5.16K shares of UROGEN PHARMA LTD. valued at approximately $38.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/10/2025ACC: 0001976408-25-000193
Officer· Chief Medical Officer
Since Jan 2019
5.16K
Shares to sell
$38.0K
Approx. market value
30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/8/2023
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/8/2023 | Restricted Stock Units N/A | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.16K
Market value
$38.0K
6/9/2025
Total
Units
5.16K
Value
$38.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/9/2025 | 5.16K | $38.0K | NASDAQ | Planned |
| Total | 5.16K | $38.0K | ||